VCTR vs VRTX · P/E 14, rev $893.5M vs P/E 30, rev $12.00B
Victory Capital Holdings Inc (VCTR) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Victory Capital Holdings Inc (VCTR) is a asset management company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported VCTR revenue for 2024-12-31 was $893.5M. Net income was $288.9M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
VCTR currently screens at market cap $4.35B and trailing P/E 14.4. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the VCTR and VRTX stock pages for the full models.
Not investment advice.